Biggest News Aggregation in the World
📰 Mutation News

Page 98 - Mutation News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Mutation. Real-time updates on events, politics, business and more.

Greater cross-neutralization against UK SARS-CoV-2 variant in vaccinated individuals with prior infection

A team of researchers in Spain has observed that, of those who have been vaccinated against SARS-CoV-2, higher titers of neutralizing antibodies for the B.1.1.7 variant (originating in the UK) were present in those who had previously been infected with the virus.
United Kingdom Jocelyn Solis Moreiramar Jocelyn Solis Moreira Coronavirus Disease Covid 19 Sars Cov 2 Corona Virus

Researchers report zoonotic spillover of adapted SARS-CoV-2 from minks to humans

Researchers report zoonotic spillover of adapted SARS-CoV-2 from minks to humans In a recent report made available on bioRxiv* preprint server, researchers from Poland and Finland reveal a spillover event of mink-adapted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from farmed mink to humans after an extensive adaptation process. st century (after SARS-CoV and MERS-CoV viruses). And while mass vaccination activities against COVID-19 are currently underway on a global level, we ...
Lukasz Rabalski University Of Gdansk National Veterinary Research Institute Intercollegiate Faculty Medical University Northern Poland

How one patient's rare mutation helped solve a mycobacterial mystery

Just because you are exposed to a pathogen does not mean you will become sick. Increasingly, scientists have shown that genetics play a central role in...
Jean Laurent Casanova Rockefeller University Immune Response Immune Cells ஜீன் பரிசு பெற்றவர் காஸநோவா ராக்ஃபெல்லர் பல்கலைக்கழகம்

How can physicians distinguish between COVID-19 persistence and SARS-CoV-2 reinfection?

How can physicians distinguish between COVID-19 persistence and SARS-CoV-2 reinfection? Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The presence of antibodies against SARS-CoV-2 in individuals who contracted COVID-19 has been well documented. Research suggests that in the majority of cases, anti-SARS-CoV-2 antibodies can persist for six months or more in those who recover from COVID-19. However, reinfection has also be...
Priyom Bose Image Credit Preferred Reporting Items Systematic Reviews Multiple Alignment Fast Fourier Transform

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Study: Monoclonal antibody 'cocktail' effective against all known COVID-19 variants

A monoclonal antibody "cocktail" developed at Vanderbilt University Medical Center (VUMC) to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published in the journal Nature Medicine.
United States University Of Texas Southwestern Medical Center United Kingdom South Africa University Of Texas James Crowe Jr

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science